Author

T. Hundal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1

Frequent Co-Authors

H. Qin· 2 shared M. E. Gadd· 2 shared Y. Luo· 2 shared Y. Qie· 2 shared A. O. Lopez· 1 shared A. Quinones-Hinojosa· 1 shared B. C. Taner· 1 shared E. S. Garavito· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Qin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Advancing CAR T-Cell Therapy: Simultaneously Attack Tumor and Immunosuppressive Cells in the Tumor Microenvironment

Y. Luo, E. S. Garavito, M. M. Brooks, M. E. Gadd, Y. Qie, M. J. U. Navas, T. Hundal, S. Li, A. O. Lopez, V. K. Jones, Y. Lou, T. Patel, R. Dronca, M. A. Kharfan-Dabaja, H. Dong, , H. Qin

This paper develops a PD-L1-targeting CAR T-cell therapy (MC9999) that effectively attacks both tumor and immunosuppressive cells in solid tumors.

bioRxiv · Mar 25, 2024 · PreprintCancer Biology

CAR T-cell therapy- Paving the way for sensitized kidney transplant patients.

T. Jarmi, Y. Luo, R. M. Attieh, Y. Qie, M. E. Gadd, T. Hundal, S. Mao, H. S. Murthy, B. C. Taner, M. Kharfan-Dabaja, H. Qin

This paper explores using CAR T-cells targeting BAFF-R to treat sensitized kidney transplant patients, showing cytotoxicity against autologous B cells and paving the way for clinical trials.

bioRxiv · Aug 24, 2023Immunology